The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein AstraZeneca’s latest vaccine woes, the compassionate use dilemma, & what it’s like to give out Covid vaccines
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Talkspace’s civic experiment, Illumina’s FTC headache, & remembering Gilead’s John Martin
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein AstraZeneca and the very good, then quite bad, then deeply confusing week
The Readout LOUD By Damian Garde and Adam Feuerstein Vaccine acceptance expert weighs in on AstraZeneca saga
The Readout LOUD By Damian Garde and Adam Feuerstein Listen: Europe’s vaccine safety scare, Lilly’s Alzheimer’s data, & a plea for transparency
The Readout LOUD By Adam Feuerstein and Meg Tirrell Listen: A U.K. take on Covid vaccines, the demise of Watson Health, and a ‘synbio’ explainer
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Peace among the pharma giants, the next phase of the pandemic, & a little Covid-19 optimism
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Covid vaccines for teens, Novavax’s remarkable rise, and the future of HHS
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Gene therapy’s safety scare, biotech’s brashest VCs, & the FDA’s uncertain future
The Readout LOUD By Adam Feuerstein, Meg Tirrell and Damian Garde The search for new Covid drugs — and a researcher’s reason for optimism
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: The state of the pandemic, the hunt for Covid-19 drugs, & meme stocks in biotech
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: 23andMe is going public, vaccine data abound, and Merck’s CEO is retiring
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: J&J’s imminent vaccine data, CRISPR’s confusing boom, and navigating scientific misinformation
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Remembering STAT’s Sharon Begley
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: JPM21: Déjà vu in Alzheimer’s research, debatable valuations in biotech, and OWS’s legacy
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Biden’s plans for biopharma, a CES preview, & the next phase of the pandemic
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Moderna’s vaccine milestone, Warp Speed’s hurdles, and biotech in 2021
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Pfizer’s Covid-19 vaccine: the debate, details, and distribution
The Readout LOUD By Adam Feuerstein, Meg Tirrell and Damian Garde A longtime health care investor on the wild ride of 2020 and what to expect in 2021
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein AstraZeneca’s confusing vaccine data, biotech in 2021, and a guide to the ASH conference
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: The latest Covid-19 vaccine data, Biden’s plans for the pandemic, and Bill Gates unfiltered
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Pfizer’s Covid-19 vaccine data, the FDA’s Alzheimer’s quandary, and how to think like a biostatistician
By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Bracing for a pandemic winter, Biogen’s fortune at the FDA, and remembering a remarkable 12-year-old
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Pfizer’s Covid-19 mystery, Ashish Jha on pandemic response, & STAT turns 5
The Readout LOUD By Damian Garde and Adam Feuerstein Listen: How the FDA thinks about Covid-19 vaccines, biotech’s SPAC fascination, & Biogen’s case in Alzheimer’s
The Readout LOUD By Damian Garde, Rebecca Robbins and Adam Feuerstein Listen: A big week for pausing studies, pharma’s statehouse spending, & how HBCUs are approaching Covid-19 trials
The Readout LOUD By Damian Garde, Rebecca Robbins and Adam Feuerstein Listen: ‘They gave me Regeneron’: How Trump’s case of Covid-19 affects biotech, medicine, and the FDA
The Readout LOUD By Damian Garde, Rebecca Robbins and Adam Feuerstein Listen: A road map for Covid-19, the gold rush in health tech, & D.C.’s pandemic unrest
The Readout LOUD By Damian Garde, Rebecca Robbins and Adam Feuerstein Listen: The CDC’s credibility crisis, pandemic PR, and virtual conference malaise
